Target intelligence / Profile preview

Mitochondrial ribosomal protein L21 pseudogene (MRPL21P)

Target
MRPL21P
Molecular classification
Other (Pseudogene), Ribosomal protein pseudogene
01

Overview

The “mitochondrial ribosomal protein L21 pseudogene” refers to one or more non-functional, processed or duplicated genomic loci derived from the MRPL21 gene, which encodes the mitochondrial ribosomal protein L21, a component of the large 39S subunit of the mitochondrial ribosome[1][2][5][8]. These pseudogenes do not produce functional proteins and are considered genomic “fossils”; they typically result from gene duplication or retrotransposition events and may contain sequence homology with the parent gene MRPL21, but lack the ability to be translated into an active protein[2][5]. No structured role has been described for these pseudogenes in translation, disease, or drug response, and they are not considered therapeutic targets. It is possible, though rarely, for pseudogenes to have regulatory functions (e.g., non-coding RNA), but no such evidence exists for this specific pseudogene[2][5].

Other names
MRPL21 pseudogenemitochondrial ribosomal protein L21 pseudogeneMRPL21PXX (where 'XX' is a variable for pseudogene numbering)pseudogene of mitochondrial ribosomal protein L21
02

Mechanism of action

null

03

Biological functions

None (no known protein-coding or regulatory function; pseudogene status)
04

Disease associations

Other (no direct disease association—functional gene associated with mitochondrial disease, but not the pseudogene)
05

Safety considerations

None (no protein product or pharmacological relevance)
06

Interacting drugs

None (as a pseudogene, it does not encode a functional protein target)
07

Biomarkers

None (no evidence for direct biomarker activity)

Beyond the preview

Go deeper on Mitochondrial ribosomal protein L21 pseudogene (MRPL21P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial ribosomal protein L21 pseudogene (MRPL21P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call